Search Results - "Anticoagulants/adverse effects"
-
1
Authors: et al.
Source: Journal of Thrombosis and Haemostasis. 23:3033-3055
Subject Terms: Low-Molecular-Weight/adverse effects, drug monitoring, Factor Xa/metabolism, Heparin, factor Xa, heparin, Treatment Outcome, Venous Thromboembolism/blood, Blood Coagulation/drug effects, Factor Xa Inhibitors/blood, Predictive Value of Tests, Risk Factors, Hemorrhage/chemically induced, low-molecular-weight, Humans, Female, Drug Dosage Calculations, venous thrombosis, Anticoagulants/adverse effects, Drug Monitoring/methods, Randomized Controlled Trials as Topic
-
2
Authors: et al.
Source: J Thromb Thrombolysis
Liu, Y, Lam, S H M, Romiti, G F, Huang, B, Chen, Y, Chao, T F, Olshansky, B, Hong, K, Huisman, M V, Lip, G Y H & GLORIA-AF Investigators 2025, 'Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III', Journal of Thrombosis and Thrombolysis, vol. 58, no. 2, pp. 165-177. https://doi.org/10.1007/s11239-025-03067-5Subject Terms: Aged, 80 and over, Male, Atrial Fibrillation/drug therapy, Myocardial Infarction, Administration, Oral, Thromboembolism/prevention & control, Atrial fibrillation, Non-vitamin K antagonist oral anticoagulants (NOACs), Oral anticoagulant, Renal function, Vitamin K antagonists (VKA), Creatinine/blood, Middle Aged, Article, Hemorrhage/chemically induced, Humans, Female, Prospective Studies, Registries, Vitamin K/antagonists & inhibitors, Anticoagulants/adverse effects, Kidney/physiopathology, Aged
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39924624
http://www.scopus.com/inward/record.url?scp=85217991158&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/771126032/Liu_et_al._2025_._Renal_function_and_adverse_clinical_events_in_anticoagulated_patients_with_atrial_fibrillation_-_insights_from_the_GLORIA-AF_Registry_Phase_III.pdf
https://doi.org/10.1007/s11239-025-03067-5
https://vbn.aau.dk/da/publications/2c7e57c1-1ba7-413d-b154-340ae1137c20
https://hdl.handle.net/11573/1733543
https://doi.org/10.1007/s11239-025-03067-5 -
3
Authors: et al.
Source: In Vivo
Subject Terms: Breast Neoplasms / surgery, Adult, Heparin, Low-Molecular-Weight / adverse effects, Heparin, Low-Molecular-Weight / therapeutic use, Breast Implantation / adverse effects, Mammaplasty, Breast Implants, Postoperative Complications / etiology, Breast Neoplasms, Anticoagulants / administration & dosage, Mammaplasty / methods, Postoperative Complications, Heparin, Low-Molecular-Weight / administration & dosage, Humans, Postoperative Complications / prevention & control, Enoxaparin, Venous Thromboembolism / prevention & control, Anticoagulants / therapeutic use, Venous Thromboembolism / etiology, Breast Implants / adverse effects, Breast Implantation, Mastectomy, Retrospective Studies, Anticoagulants / adverse effects, Hematoma, Mastectomy / adverse effects, Mastectomy / methods, Anticoagulants, Breast Implantation / methods, Venous Thromboembolism, Middle Aged, Heparin, Low-Molecular-Weight, Hematoma / prevention & control, LMWH, Mammaplasty / adverse effects, Treatment Outcome, Hematoma / etiology, Female, Venous thromboembolism, Research Article
File Description: application/pdf
-
4
Authors: et al.
Source: Journal of Thrombosis and Haemostasis. 22:2834-2843
Subject Terms: Adult, Heparin, Low-Molecular-Weight / adverse effects, Heparin, Low-Molecular-Weight / therapeutic use, Injections, Subcutaneous, Hospitals, Maternity, Anticoagulants / administration & dosage, Risk Assessment, Postpartum Hemorrhage / prevention & control, Pregnancy, Risk Factors, Heparin, Low-Molecular-Weight / administration & dosage, Humans, Patient preference, Low-molecular-weight heparin, Venous Thromboembolism / prevention & control, Anticoagulants / therapeutic use, Anticoagulants / adverse effects, Venous Thrombosis, Pulmonary Embolism / prevention & control, Postpartum Period, Postpartum Hemorrhage, Venous Thrombosis / prevention & control, Anticoagulants, Patient Preference, Postpartum period, Venous Thromboembolism, Heparin, Low-Molecular-Weight, Quality of Life, Female, France, Pulmonary Embolism, Switzerland, Venous thromboembolism
File Description: application/pdf
-
5
Authors: et al.
Source: Pediatr Nephrol
Pediatric nephrology., New York : Springer, 2024, vol. 39, iss. 11, p. 3353-3362.Subject Terms: Male, Continuous Kidney Replacement Therapy, Time Factors, Continuous Renal Replacement Therapy, Heparin, Regional Citrate Anticoagulation, Anticoagulants/administration, Continuous Renal Replacement Therapy/methods [MeSH], Original Article, Infant [MeSH], Male [MeSH], Acute Kidney Injury/etiology [MeSH], Registries/statistics, Continuous Renal Replacement Therapy/statistics, Child [MeSH], Acute Kidney Injury/therapy [MeSH], Female [MeSH], Anticoagulants/adverse effects [MeSH], Acute Kidney Injury/epidemiology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Circuit lifetime, Treatment Outcome [MeSH], Continuous Renal Replacement Therapy/instrumentation [MeSH], Regional citrate anticoagulation, What's New in Dialysis, Acute kidney injury, Continuous kidney replacement therapy, Time Factors [MeSH], Heparin/administration, Anticoagulants/therapeutic use [MeSH], Child, Preschool [MeSH], Infant, Anticoagulants, acute kidney injury, circuit lifetime, continuous kidney replacement therapy, regional citrate anticoagulation, Acute Kidney Injury, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Child, Preschool, Circuit Lifetime, Humans, Female, Registries, Prospective Studies, Child
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39023538
https://hdl.handle.net/2434/1116121
https://doi.org/10.1007/s00467-024-06459-6
https://repository.publisso.de/resource/frl:6521687
https://repository.vu.lt/VU:ELABAPDB208642395&prefLang=en_US
https://hdl.handle.net/11454/104210
https://doi.org/10.1007/s00467-024-06459-6 -
6
Authors: et al.
Source: Stroke Vasc Neurol
Stroke and Vascular Neurology, Vol, Iss
Stroke and vascular neurology, vol. 9, no. 6, pp. 640-651
Siepen, Bernhard M; Forfang, Elisabeth; Branca, Mattia; Drop, Boudewijn; Müller, Madlaine; Göldlin, Martina B; Katan, Mira; Michel, Patrik; Cereda, Carlo; Medlin, Friedrich; Peters, Nils; Renaud, Susanne; Niederhauser, Julien; Carrera, Emmanuel; Kahles, Timo; Kägi, Georg; Bolognese, Manuel; Salmen, Stephan; Mono, Marie-Luise; Polymeris, Alexandros A; ... (2024). Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries. (In Press). Stroke and vascular neurology BMJ 10.1136/svn-2023-002813 <http://dx.doi.org/10.1136/svn-2023-002813>
Siepen, Bernhard M; Forfang, Elisabeth; Branca, Mattia; Drop, Boudewijn; Müller, Madlaine; Göldlin, Martina B; Katan, Mira; Michel, Patrik; Cereda, Carlo; Medlin, Friedrich; Peters, Nils; Renaud, Susanne; Niederhauser, Julien; Carrera, Emmanuel; Kahles, Timo; Kägi, Georg; Bolognese, Manuel; Salmen, Stephan; Mono, Marie-Luise; Polymeris, Alexandros A; ... (2024). Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries. Stroke and vascular neurology, 9(6), pp. 640-651. BMJ 10.1136/svn-2023-002813 <http://dx.doi.org/10.1136/svn-2023-002813>Subject Terms: Male, 616.8, Time Factors, Vitamin K, Administration, Oral, 610 Medicine & health, Hemorrhage, Stroke / drug therapy, Anticoagulants / administration & dosage, Risk Assessment, Risk Factors, Vitamin K / antagonists & inhibitors, Humans, Registries, RC346-429, Cerebral Hemorrhage / mortality, Original Research, Aged, Cerebral Hemorrhage, Anticoagulants / adverse effects, Aged, 80 and over, Factor Xa Inhibitors / administration & dosage, Norway, Stroke / epidemiology, Cerebral Hemorrhage / chemically induced, Factor Xa Inhibitors / adverse effects, Anticoagulants, Female, Anticoagulants/adverse effects, Anticoagulants/administration & dosage, Cerebral Hemorrhage/mortality, Cerebral Hemorrhage/chemically induced, Treatment Outcome, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/administration & dosage, Norway/epidemiology, Switzerland, Middle Aged, Vitamin K/antagonists & inhibitors, Functional Status, Recovery of Function, Stroke/mortality, Stroke/diagnosis, Stroke/drug therapy, Stroke/epidemiology, Stroke, Stroke / mortality, 3. Good health, Stroke / diagnosis, Norway / epidemiology, Neurology. Diseases of the nervous system, Factor Xa Inhibitors
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38336370
https://doaj.org/article/087545d9700a4acd9b22a7c325dfeda5
https://serval.unil.ch/notice/serval:BIB_FE2740DA293B
https://serval.unil.ch/resource/serval:BIB_FE2740DA293B.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_FE2740DA293B7
https://boris.unibe.ch/192780/ -
7
Authors: et al.
Source: J Clin Endocrinol Metab
Bucci, T, Nabrdalik, K, Baratta, F, Pastori, D, Pignatelli, P, Hydes, T, Alam, U, Violi, F & Lip, G Y H 2025, 'Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease', The Journal of clinical endocrinology and metabolism, vol. 110, no. 1, dgae394, pp. 208-217. https://doi.org/10.1210/clinem/dgae394Subject Terms: Male, Administration, Oral, Thromboembolism/prevention & control, Hemorrhage, Warfarin/adverse effects, cardiovascular events, all-cause death, Non-alcoholic Fatty Liver Disease, Risk Factors, Hemorrhage/chemically induced, Thromboembolism, Atrial Fibrillation, Humans, atrial fibrillation, Retrospective Studies, Aged, Aged, 80 and over, Clinical Research Article, Non-alcoholic Fatty Liver Disease/complications, non-alcoholic fatty liver disease, Anticoagulants, Middle Aged, bleeding, 3. Good health, Female, Warfarin, Anticoagulants/adverse effects, Atrial Fibrillation/complications
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38864452
http://www.scopus.com/inward/record.url?scp=85206191569&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/dbbd1ba0-e803-4a02-8950-e68fe065ff5c
https://vbn.aau.dk/ws/files/761200526/Bucci_et_al._2025_._Risk_of_Adverse_Events_in_Anticoagulated_Patients_With_Atrial_Fibrillation_and_Nonalcoholic_Fatty_Liver_Disease.pdf
https://doi.org/10.1210/clinem/dgae394
https://hdl.handle.net/11573/1711663
https://doi.org/10.1210/clinem/dgae394 -
8
Authors: et al.
Source: J Thromb Thrombolysis
Subject Terms: Male, Hemorrhage, Major bleeding, Aged [MeSH], Factor Xa Inhibitors/therapeutic use [MeSH], Neoplasms/mortality [MeSH], Hemorrhage/mortality [MeSH], Venous Thromboembolism/etiology [MeSH], Cohort Studies [MeSH], Male [MeSH], Venous Thromboembolism/drug therapy [MeSH], Sweden/epidemiology [MeSH], Venous Thromboembolism/epidemiology [MeSH], Heparin, Low-Molecular-Weight/adverse effects [MeSH], Venous Thromboembolism/mortality [MeSH], Cancer-associated thrombosis, Female [MeSH], Anticoagulants/adverse effects [MeSH], Hemorrhage/chemically induced [MeSH], Humans [MeSH], Factor Xa Inhibitors/adverse effects [MeSH], Incidence [MeSH], Rivaroxaban/adverse effects [MeSH], Middle Aged [MeSH], Rivaroxaban/therapeutic use [MeSH], Low molecular weight heparin, Recurrent venous thromboembolism, Article, Neoplasms/complications [MeSH], Neoplasms/drug therapy [MeSH], Heparin, Low-Molecular-Weight/therapeutic use [MeSH], Anticoagulants/therapeutic use [MeSH], Rivaroxaban, Registries [MeSH], Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Humans, Registries, Aged, Sweden, Incidence, Anticoagulants, Venous Thromboembolism, Middle Aged, Heparin, Low-Molecular-Weight, Female, Factor Xa Inhibitors
File Description: application/pdf
-
9
Authors: et al.
Source: Scand J Trauma Resusc Emerg Med
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 33, Iss 1, Pp 1-16 (2025)Subject Terms: Oral, Prothrombin complex concentrate, RC86-88.9, Bleeding, Anticoagulants, Administration, Oral, Medical emergencies. Critical care. Intensive care. First aid, Hemorrhage, Review, Blood Coagulation Factors/therapeutic use, Blood Coagulation Factors, Direct oral anticoagulants, Hemorrhage/chemically induced, Administration, Systematic review, Quality of Life, Humans, Vitamin K antagonist, Anticoagulants/adverse effects, Randomized Controlled Trials as Topic
-
10
Authors: et al.
Source: Binding, C, Blanche, P, Lip, G Y H, Kamper, A-L, Lee, C J Y, Staerk, L, Gislason, G, Torp-Pedersen, C, Olesen, J B & Bonde, A N 2024, 'Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 10, no. 3, pvae016, pp. 210-218. https://doi.org/10.1093/ehjcvp/pvae016
Subject Terms: Male, Time Factors, Denmark, Administration, Oral, Thromboembolism/prevention & control, Hemorrhage, Major bleeding, Kidney, Glomerular Filtration Rate/drug effects, Risk Assessment, Direct oral anticoagulants, 03 medical and health sciences, Kidney function, 0302 clinical medicine, Pyridones/adverse effects, Risk Factors, Hemorrhage/chemically induced, Pyrazoles/adverse effects, Thromboembolism, Atrial Fibrillation, Humans, Registries, Factor Xa Inhibitors/adverse effects, Stroke/prevention & control, Aged, Aged, 80 and over, Atrial Fibrillation/drug therapy, Anticoagulants, Middle Aged, Atrial fibrillation, Denmark/epidemiology, 3. Good health, Stroke, Treatment Outcome, Female, Anticoagulants/adverse effects, Kidney/physiopathology, Glomerular Filtration Rate, Factor Xa Inhibitors
Access URL: https://pubmed.ncbi.nlm.nih.gov/38402466
-
11
Authors: et al.
Source: Søgaard, M, Jensen, M, Højen, A A, Larsen, T B, Lip, G Y H, Ording, A G & Nielsen, P B 2024, 'Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study', Stroke, vol. 55, no. 2, pp. 413-422. https://doi.org/10.1161/STROKEAHA.123.044407
Subject Terms: Male, Frail Elderly, Hemorrhage, frailty, Stroke/epidemiology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort studies, Hemorrhage/chemically induced, Thromboembolism, Atrial Fibrillation, Humans, atrial fibrillation, Aged, Thromboembolism/epidemiology, Frailty, Frailty/epidemiology, Anticoagulants, thromboembolism, 3. Good health, Stroke, Female, hemorrhage, Anticoagulants/adverse effects, Atrial Fibrillation/complications
Access URL: https://pubmed.ncbi.nlm.nih.gov/38252753
-
12
Authors: et al.
Source: JACC: Cardiovascular Interventions. 17:405-418
Subject Terms: Vitamin K, Non–vitamin K antagonist oral anticoagulant, Aortic Valve / diagnostic imaging, Hemorrhage, Aortic valve stenosis, Aortic Valve Stenosis / surgery, Transcatheter Aortic Valve Replacement / adverse effects, Transcatheter Aortic Valve Replacement, Aortic Valve / surgery, Fibrinolytic Agents, Aortic Valve Stenosis / diagnostic imaging, Humans, Prospective Studies, Anticoagulants / adverse effects, Stroke / etiology, Anticoagulants, Aortic Valve Stenosis, Transcatheter aortic valve replacement, 3. Good health, Stroke, Treatment Outcome, Oral anticoagulation, Hemorrhage / chemically induced, Aortic Valve, Vitamin K antagonist, Aortic Valve Stenosis / complications, Stroke / prevention & control
File Description: application/pdf
-
13
Authors: et al.
Contributors: et al.
Source: Catheterization and cardiovascular interventions
Subject Terms: Platelet Aggregation Inhibitors/adverse effects, Mitral Valve/diagnostic imaging, Anticoagulants, Fibrinolytic Agents/adverse effects, Hemorrhage, Thrombosis, 3. Good health, Treatment Outcome, Fibrinolytic Agents, Hemorrhage/chemically induced, Humans, Mitral Valve, Human medicine, Registries, Anticoagulants/adverse effects, Thrombosis/etiology, Platelet Aggregation Inhibitors
Access URL: https://pubmed.ncbi.nlm.nih.gov/38078877
https://hdl.handle.net/10067/2021640151162165141
https://biblio.vub.ac.be/vubir/(46bd0197-a423-45d9-bed4-529d67f3206b).html -
14
Authors: et al.
Source: Verma, L A, Penson, P E, Akpan, A, Lip, G Y H & Lane, D A 2023, 'Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches', Expert Review of Cardiovascular Therapy, vol. 21, no. 12, pp. 963-983. https://doi.org/10.1080/14779072.2023.2276892
Subject Terms: Stroke/etiology, multimorbidity, Frailty, non-vitamin K antagonist oral anticoagulants, Anticoagulants, Administration, Oral, frailty, Multiple Chronic Conditions/drug therapy, stroke, 3. Good health, older people, Stroke, vitamin K antagonists, Risk Factors, Frailty/complications, Atrial Fibrillation, Humans, atrial fibrillation, Multiple Chronic Conditions, Anticoagulants/adverse effects, Atrial Fibrillation/complications, Aged
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38088256
http://www.scopus.com/inward/record.url?scp=85179646118&partnerID=8YFLogxK
https://doi.org/10.1080/14779072.2023.2276892
https://vbn.aau.dk/da/publications/cc0599b7-7cf6-47c8-8940-08da9d821573
https://vbn.aau.dk/ws/files/630980977/Verma_et_al._2023_._Managing_older_people_with_atrial_fibrillation_and_preventing_stroke_a_review_of_anticoagulation_approaches.pdf -
15
Authors: et al.
Contributors: et al.
Source: Lancet Neurology, 22, 12, pp. 1140-1149
Al-Shahi Salman, R, Stephen, J, Tierney, J F, Lewis, S C, Newby, D E, Parry-Jones, A R, White, P M, Connolly, S J, Benavente, O R, Dowlatshahi, D, Cordonnier, C, Viscoli, C M, Sheth, K N, Kamel, H, Veltkamp, R, Larsen, K T, Hofmeijer, J, Kerkhoff, H, Schreuder, F H B M, Shoamanesh, A, Klijn, C J M, van der Worp, H B, Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH) & Kruuse, C 2023, ' Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH) : prospective, individual participant data meta-analysis of randomised trials ', The Lancet Neurology, vol. 22, no. 12, pp. 1140-1149 . https://doi.org/10.1016/S1474-4422(23)00315-0
Al-Shahi salman, R, Stephen, J, Tierney, J F, Lewis, S C, Newby, D E, Parry-Jones, A R, White, P M, Connolly, S J, Benavente, O R, Dowlatshahi, D, Cordonnier, C, Viscoli, C M, Sheth, K N, Kamel, H, Veltkamp, R, Larsen, K T, Hofmeijer, J, Kerkhoff, H, Schreuder, F H B M, Shoamanesh, A, Klijn, C J M, Van der worp, H B 2023, ' Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials ', The Lancet Neurology . https://doi.org/10.1016/S1474-4422(23)00315-0
Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH) 2023, 'Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH) : prospective, individual participant data meta-analysis of randomised trials', The Lancet. Neurology, vol. 22, no. 12, pp. 1140-1149. https://doi.org/10.1016/S1474-4422(23)00315-0
The Lancet NeurologySubject Terms: Radboud University Medical Center, Anticoagulants, Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience, 16. Peace & justice, 3. Good health, [SDV] Life Sciences [q-bio], Stroke, Intracranial Hemorrhages/chemically induced, Atrial Fibrillation, Humans, Prospective Studies, Anticoagulants/adverse effects, Atrial Fibrillation/complications, Stroke/prevention & control, Intracranial Hemorrhages, Randomized Controlled Trials as Topic
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37839434
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/300023
https://doi.org/10.1016/S1474-4422(23)00315-0
https://hdl.handle.net/10037/31985
http://hdl.handle.net/10852/106404
https://doi.org/10.1016/S1474-4422(23)00315-0
https://hdl.handle.net/2066/300023
https://repository.ubn.ru.nl//bitstream/handle/2066/300023/300023.pdf
https://curis.ku.dk/ws/files/409637192/1_s2.0_S1474442223003150_main.pdf
https://www.pure.ed.ac.uk/ws/files/387030913/PIIS1474442223003150_1_.pdf
https://hdl.handle.net/20.500.11820/0b7857b3-717f-454d-aa25-63ebfa88c9cb
https://hal.univ-lille.fr/hal-04794302v1/document
https://doi.org/10.1016/s1474-4422(23)00315-0
https://hal.univ-lille.fr/hal-04794302v1
https://discovery-pp.ucl.ac.uk/id/eprint/10179656/ -
16
Authors: et al.
Contributors: et al.
Source: Clin Res Cardiol
Subject Terms: Male, Original Paper, Time Factors, Incidence, Administration, Oral, Anticoagulants, Middle Aged, Antithrombins, 3. Good health, Dabigatran, Treatment Outcome, Intracranial Embolism, Pulmonary Veins, Atrial Fibrillation, Pulmonary vein isolation, Anticoagulants/administration, Aged [MeSH], Atrial Fibrillation/diagnosis [MeSH], Administration, Oral [MeSH], Dabigatran/administration, Stroke, Atrial Fibrillation/surgery [MeSH], Male [MeSH], Catheter Ablation/adverse effects [MeSH], Oral anticoagulation, Intracranial Embolism/prevention, Female [MeSH], Anticoagulants/adverse effects [MeSH], Dabigatran/adverse effects [MeSH], Follow-Up Studies [MeSH], Atrial Fibrillation/complications [MeSH], Intracranial Embolism/etiology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Cerebral microembolism, Treatment Outcome [MeSH], Incidence [MeSH], Catheter Ablation/methods [MeSH], Antithrombins/administration, Middle Aged [MeSH], Atrial fibrillation, Pulmonary Veins/surgery [MeSH], Time Factors [MeSH], Intracranial Embolism/epidemiology [MeSH], Antithrombins/adverse effects [MeSH], Catheter Ablation, Humans, Female, Prospective Studies, Aged, Follow-Up Studies
File Description: pdf
-
17
Authors: et al.
Source: Krittayaphong, R, Treewaree, S, Wongtheptien, W, Kaewkumdee, P & Lip, G Y H 2024, 'Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial fibrillation Better Care (ABC) pathway: A report from the COOL-AF registry', QJM: An International Journal of Medicine, vol. 117, no. 1, hcad219, pp. 16-23. https://doi.org/10.1093/qjmed/hcad219
Subject Terms: Male, Embolism, Anticoagulants, Middle Aged, Stroke/epidemiology, 3. Good health, Stroke, Phenotype, Risk Factors, Atrial Fibrillation, Humans, Female, Registries, Anticoagulants/adverse effects, Atrial Fibrillation/complications, Aged
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37788118
http://www.scopus.com/inward/record.url?scp=85184582393&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/c630e4d8-aa2d-4e99-9262-33c9f21b2cb0
https://doi.org/10.1093/qjmed/hcad219
https://vbn.aau.dk/ws/files/552435724/Krittayaphong_et_al._2023_._Clinical_phenotype_classification_to_predict_risk_and_optimize_the_management_of_patients_with_atrial_fibrillation_using_the_Atrial_fibrillation_Better_Care_ABC_pathway_A_report_from_the_COOL-.pdf -
18
Authors: et al.
Contributors: et al.
Source: ISSN: 1875-2136.
Subject Terms: Chronic coronary syndrome, Stent, Oral anticoagulation, Aspirin, MESH: Administration, Oral, MESH: Anticoagulants* / administration & dosage, MESH: Drug Administration Schedule, MESH: Fibrinolytic Agents* / administration & dosage, MESH: Fibrinolytic Agents* / adverse effects, MESH: Hemorrhage / chemically induced, MESH: Humans, MESH: Multicenter Studies as Topic, MESH: Percutaneous Coronary Intervention* / adverse effects, MESH: Percutaneous Coronary Intervention* / instrumentation, MESH: Percutaneous Coronary Intervention* / mortality, MESH: Platelet Aggregation Inhibitors* / administration & dosage, MESH: Anticoagulants* / adverse effects, MESH: Platelet Aggregation Inhibitors* / adverse effects, MESH: Prospective Studies, MESH: Randomized Controlled Trials as Topic, MESH: Recurrence, MESH: Risk Assessment, MESH: Risk Factors, MESH: Stents, MESH: Time Factors, MESH: Treatment Outcome, MESH: Aspirin* / administration & dosage, MESH: Aspirin* / adverse effects, MESH: Coronary Artery Disease* / diagnosis
Relation: info:eu-repo/semantics/altIdentifier/pmid/40011110; PUBMED: 40011110
Availability: https://hal.science/hal-05109967
https://hal.science/hal-05109967v1/document
https://hal.science/hal-05109967v1/file/Didier%20et%20al.%20-%202025%20-%20Assessment%20of%20quitting%20versus%20using%20aspirin%20therapy%20in%20patients%20with%20stabilized%20coronary%20artery%20dise.pdf
https://doi.org/10.1016/j.acvd.2025.01.006 -
19
Authors: et al.
Source: Lip, G Y H, Benamouzig, R, Martin, A-C, Pesce, G, Gusto, G, Quignot, N, Khachatryan, A, Dai, F, Sedjelmaci, F, Chaves, J, Subash, R & Mokgokong, R 2025, 'Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS)', PLOS ONE, vol. 20, no. 1, e0317895. https://doi.org/10.1371/journal.pone.0317895
Subject Terms: Humans, Atrial Fibrillation/drug therapy, Gastrointestinal Hemorrhage/chemically induced, Aged, Male, Female, Anticoagulants/adverse effects, France/epidemiology, Administration, Oral, 80 and over, Rivaroxaban/adverse effects, Pyridones/adverse effects, Pyrazoles/adverse effects, Dabigatran/adverse effects, Risk Factors, Middle Aged, Cohort Studies, Databases, Factual, Stroke/prevention & control, Vitamin K/antagonists & inhibitors
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39841678; info:eu-repo/semantics/altIdentifier/pissn/1932-6203; info:eu-repo/semantics/altIdentifier/eissn/1932-6203
Availability: https://vbn.aau.dk/da/publications/d1c1d91a-d80a-4a6c-9614-4c648c7e8d5f
https://doi.org/10.1371/journal.pone.0317895
https://vbn.aau.dk/ws/files/767580004/Lip_et_al._2025_._Comparative_safety_and_effectiveness_of_oral_anticoagulants_in_key_subgroups_of_patients_with_non-valvular_atrial_fibrillation_and_at_high_risk_of_gastrointestinal_bleeding_A_cohort_study_based_on_the_Fre.pdf
https://www.scopus.com/pages/publications/85216375044 -
20
Authors: et al.
Source: Journal of critical care, vol. 87, pp. 155032
Subject Terms: Humans, Continuous Renal Replacement Therapy/adverse effects, Female, Male, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Middle Aged, Citric Acid/administration & dosage, Citric Acid/adverse effects, Aged, Retrospective Studies, Intensive Care Units, Risk Factors, Acute Kidney Injury/therapy, Acute kidney injury, Citrate accumulation, Continuous renal replacement therapy, Metabolic complications, Regional citrate anticoagulation
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39954302; info:eu-repo/semantics/altIdentifier/eissn/1557-8615; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BBD993DAC6655; https://serval.unil.ch/notice/serval:BIB_BBD993DAC665; https://serval.unil.ch/resource/serval:BIB_BBD993DAC665.P001/REF.pdf
Nájsť tento článok vo Web of Science 
Full Text Finder 
Full Text